Drug intelligence / Profile preview

carmellose sodium + hyaluronic acid

Development stage
Unknown
Lead developer
Allergan
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

This is a combination ophthalmic formulation containing carmellose sodium (also known as carboxymethylcellulose sodium, CMC) and hyaluronic acid (HA, often in the form of its salt, sodium hyaluronate). Both are polymers used as lubricants and artificial tears for the symptomatic relief of dry eye disease. Carmellose sodium acts by binding to corneal epithelial cells via glucose receptors, increasing tear film stability and promoting corneal healing. Hyaluronic acid provides viscoelasticity and water retention, mimicking natural tears to hydrate and protect the ocular surface. The combination leverages both agents' lubricating properties to improve symptoms of dry eye more effectively than either alone in some studies. This product is primarily indicated for dry eye syndrome but may also be used post-ocular surgery or for other causes of ocular surface irritation[2][3][5][6].

Brand names
Seprafilm
Other names
carboxymethylcellulose sodium + hyaluronic acidCMC + HAsodium carboxymethylcellulose + sodium hyaluronate
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on carmellose sodium + hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carmellose sodium + hyaluronic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call